Genascence News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genascence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genascence Today - Breaking & Trending Today

Genascence to Present at Biotech Showcase 2024

/PRNewswire/ Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal. ....

San Francisco , United States , Thomas Chalberg , Genascence Corporation , Union Square , Biotech Showcase , Hilton San Francisco , Ballroom Level ,

Genascence to Present Full Data from Phase 1 Clinical Trial on GNSC-001, Company's Lead Program in Osteoarthritis, at European Society of Gene & Cell Therapy 30th Annual Congress

/PRNewswire/ Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal. ....

Bruxelles Capitale , United States , Thomas Chalberg , Annahita Keravala , Genascence Corporation , European American Society Of Gene , European American Society , Cell Therapy , Annual Congress , Defense Peer Reviewed Medical Research Program , Health Care Amp Hospitals , Pharmaceuticals , Medical Pharmaceuticals , Clinical Trials Amp Medical Discoveries , Trade Show News ,

Genascence Names Ian Lachlan McLean, M.D. Ph.D. as Chief Medical Officer

/PRNewswire/ Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal. ....

New Zealand , City Of , United Kingdom , United States , Ian Lachlan Lachy Mclean , Thomas Chalberg , University Of London , Ut Southwestern Medical Center , Prnewswire Genascence Corporation , University Of Otago , Ian Lachlan , Investigational New Drug , Clinical Trial Authorization , Medical Center ,

Genascence Announces Data From Phase 1 Clinical Trial on GNSC-001, Company's Lead Program in Osteoarthritis, Presented at American Society of Gene & Cell Therapy 25th Annual Meeting

/PRNewswire/ Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal. ....

District Of Columbia , United States , Thomas Chalberg , Christopherh Evans , American Society Of Gene , Waltere Washington Convention Center , Genascence Corporation , American Society , Cell Therapy , Annual Meeting , Phasei Trial , Osteoarthritis Gene Therapy , Cell Therapy Trials , Convention Center , Defense Peer Reviewed Medical Research Program ,

Genascence Announces First Close in Series A Financing led by Pacira BioSciences and Expands Board of Directors and Scientific Advisory Board

Proceeds will be used to advance clinical program of GNSC-001, company s lead candidate in osteoarthritis (OA) Brian Kotzin, M.D., and Jackson Streeter, M.D.,. ....

United States , National Institutes Of Health , Palo Alto , Stanford University , University Of Maryland School Medicine , Brian Kotzin , Paul Robbins , Byers Kraus , Philip Conaghan , Marcc Hochberg , Pacira Biosciences , Steven Ghivizzani , Mukundan Attur , Thomasj Schnitzer , Ron Ellis , John Fraser Wright , Thomas Chalberg , Christopherh Evans , Annahita Keravala , American Society For Gene Cell Therapy , Duke University School Of Medicine , Musculoskeletal Gene Therapy Research Laboratory , Pacira Biosciences Inc , Oncorus Inc , University Of Florida Ventures , American Society Of Gene Cell Therapy ,